micro-community-banner
Profile Image
  • Saved

The risk of ischemic stroke and hemorrhagic stroke in Chinese adults with low-density lipoprotein cholesterol concentrations < 70 mg/dL

The risk of ischemic stroke and hemorrhagic stroke in Chinese adults with low-density lipoprotein cholesterol concentrations < 70 mg/dL

Source : https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-021-02014-4

Background The risk of stroke in individuals with very low low-density lipoprotein cholesterol (LDL-C) concentrations remains high. We sought to prioritize predictive risk factors for stroke in Chinese participants with...

Profile Image
  • Saved

Profile Image
  • Saved

Circulating miRNAs miR-574-5p and miR-3135b are potential metabolic regulators for serum lipids and blood glucose in gestational diabetes mellitus

Circulating miRNAs miR-574-5p and miR-3135b are potential metabolic regulators for serum lipids and blood glucose in gestational diabetes mellitus

Source : https://doi.org/10.1080/09513590.2021.1908990

Abstract MicroRNAs (miRNAs) are potentially involved in the regulation of glucose and lipid metabolism. The aim of this study was to investigate potential miRNA regulators for serum lipids and blood...

Profile Image
  • Saved

Novel biomarker panel measuring endothelial injury identifies patients at risk of coronary artery syndrome and discordance with low-density lipoprotein cholesterol.

Source : https://europepmc.org/article/med/34138801

Background Individuals with no history of coronary artery disease can develop acute coronary syndrome (ACS), often in the absence of major risk factors including low-density lipoprotein cholesterol (LDL-C). We identified...

Profile Image
  • Saved

Is There Less Aggressive Lipid Management in PAD Patients? - American College of Cardiology

Is There Less Aggressive Lipid Management in PAD Patients? - American College of Cardiology

Source : https://www.acc.org/latest-in-cardiology/articles/2021/06/14/20/40/is-there-less-aggressive-lipid-management-in-pad-patients

For patients with peripheral artery disease (PAD), intensity of lipid-lowering therapy may be a "poor surrogate" for achieved LDL-cholesterol (LDL-C), as achieved LDL-C levels remain elevated for the majority of...

Profile Image